Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Lilly plans to launch a series of local pharma blogs

Pharma company is preparing to extend its Lilly Pad corporation blog

A year and a half after launching a US-based corporate blog Eli Lilly & Company is preparing to allow some of its local operations to join the blogosphere.

Writing on the pharma company's LillyPad blog Greg Kueterman said: “Some of our affiliate businesses in other countries will soon be launching their own versions of LillyPad, and you'll see some posts from those countries right here (as long as it's relevant to our broader audience).

“Conversely, some of our posts in the US will start appearing in overseas editions.”

Lilly, which has been running LillyPad since October 2010, has also given the corporate blog a new look, with a re-designed landing page, new search function and a featured posts section to ensure key content can be effectively highlighted.

Blogging, one of the most time consuming areas of social media, seems to be having something of a resurgence in pharma.

In addition to Lilly's expansion of LillyPad, Boehringer Ingelheim announced its own plans earlier this year to launch its first blog.

The German pharma company's new blog will be called The Future Just Happened and Boehringer's head of online communications John Pugh told PMLiVE in January he was looking to work with a range of guest bloggers, including patients.

The number of pharma company blogs has slowly increase since Johnson & Johnson launched the industry's first, JnJ BTW, in 2007. Now seven of the top ten pharma companies run their own blogs, including GSK (More Than Medicine), AstraZeneca (AZ Health Connections) and Sanofi (Discuss Diabetes).

27th March 2012

From: Marketing

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

Genetic Digital provides strategically driven digital solutions for healthcare, pharma & life sciences brands so they can optimise their web...

Latest intelligence

When forecasters take the floor: 6 tips on presenting a forecast
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast...
Enablers of drug innovation could lie in the numbers
Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem....
Forecasting for Licensed Compounds
Peter Mansell examines the impact of heavier in-licensing/out-licensing traffic on pharmaceutical forecasting...

Infographics